Clinic Study of Sanweiyiti Integrated Treatment to Improve Pediatric Hydrocephalus Mental Pressure Function and Intelligence Level

Sanweiyiti Integrated Treatment for Pediatric Hydrocephalus in Normal Pressure

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-TRC-11001659

Enrollment

Unknown

Registered

2011-11-04

Start date

2007-02-02

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pediatric Hydrocephalus in Normal Pressure

Interventions

experimental group:Sanweiyiti Integrated Treatment

Eligibility

Sex/Gender

All

Age

1 Years to 14 Years

Inclusion criteria

Inclusion criteria: 1. The patients agree to participate in the clinical trial and sign a written consent document; 2. The patients should be between 1 to 14 years old, without sex limitation; 3. The symptoms of the patients' should be in line with the western medicine pediatric hydrocephalus diagnosis standard, with symptoms of psychomotor retardation, mental decline, or poor learning ability.

Exclusion criteria

Exclusion criteria: 1. Patients who are allergic to the known components of the drug or allergic people; 2. Patients who have diseases, such as cardiovascular, liver and kidney and hematopoietic system and other severe primary disease, or psychiatric patients; 3. Patients who have severe diseases and cannot evaluate the effectiveness and safety of the treatment; 4. Patients who without psychomotor dysfunction or intellectual underserved.

Design outcomes

Primary

Measure	Time frame
Intelligence;Psychomoto;	—

Countries

China

Contacts

Public ContactSong Hujie

13909231298@139.com+86 13909231298

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026